Argent Trust Company’s Novo Nordisk NVO Stock Holding History

Argent Trust Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-17,992	Closed	-$411K	–	175
2014 Q1	$411K	Buy	17,992 +642	+4%	+$13.7K	0.15%	117
2013 Q4	$321K	Hold	17,350	–	–	0.12%	124
2013 Q3	$294K	Buy	+17,350	New	+$292K	0.12%	116

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Argent Trust Company's NVO Position: Q2 2014 in Review

Argent Trust Company sold out of Novo Nordisk (NVO) in Q2 2014, closing a stake of 17,992 shares — an estimated $411K sold.

Argent Trust Company first reported a position in NVO in Q3 2013 and held it in 3 quarters. The position peaked at $411K in Q1 2014. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

Argent Trust Company reported no remaining Novo Nordisk position as of Q2 2014 after selling out during the quarter.
Argent Trust Company sold 17,992 Novo Nordisk shares in Q2 2014, an estimated $411K.
Argent Trust Company first reported a position in Novo Nordisk in Q3 2013 and held it in 3 quarters.
Argent Trust Company's Novo Nordisk position peaked at $411K in Q1 2014.
473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on Argent Trust Company's 13F filing for Q2 2014, filed 8 Aug 2014.